Specialized Gynec Pharma Brand Raising Funds In Indore

About Business

This is a pharmaceutical business engaged in the marketing and distribution of gynecology, obstetrics, and infertility products. The company focuses on building brands, reaching doctors, and expanding its distribution network, while keeping manufacturing outsourced to third-party facilities.

Background
The business started in 2016 as a private limited company and was later converted into a public limited company in 2022. It is led by a promoter with over 30 years of experience in the pharma industry, particularly in the gynecology segment, which is reflected in the product selection and market approach.

Product portfolio
The company has built a portfolio of 42 brands, out of which 17 are registered. A few of these brands are already performing well in the market and are receiving consistent prescriptions from doctors. The portfolio covers a wide range of gynecological needs, with formulations based on approved combinations.

Operations
Manufacturing is handled through third-party units based in Baddi, Himachal Pradesh. This keeps the business asset-light and avoids large capital investment in plant and machinery. The company instead focuses on marketing, doctor engagement, and distribution efficiency.

Market presence
The business has developed a steady presence in Madhya Pradesh, Rajasthan, Maharashtra, and Uttar Pradesh. It has an established network in these regions and continues to build relationships with healthcare professionals.

Growth outlook
With an existing base in key North and Central Indian markets, the company has room to scale by expanding geographically and strengthening its current brands. Demand in the gynecology and fertility segment continues to grow, supporting further expansion.

Clientele type

The business operates in the healthcare industry, serving clients across Madhya Pradesh, Uttar Pradesh, Maharashtra, and Rajasthan.

Premises

LEASED

Lease per month (in INR): 1.50 L

Security Deposit (in INR): 3.00 L

Carpet Area: 5,000 sq ft

Asking Price Includes

The terms will be mutually discussed and finalized with prospective investors.

Asking Price

INR 5.00 Cr

Minimum ticket size

INR 5.00 Cr

Reason

The company is looking to raise capital primarily to manage working capital needs. Additional funds will help in maintaining inventory, improving supply cycles, and supporting expansion into new markets.

Licenses

GST Registration, Drug License, and FSSAI License

More Details

The organization has a structured on-ground team consisting of 10 managers who oversee regional operations and sales performance. They are supported by a field force of 30 medical representatives responsible for doctor engagement, product promotion, and market development across key territories. In addition, there is a 5-member office team handling administrative, coordination, and backend support functions to ensure smooth day-to-day operations and execution.